NewsVertex Pharmaceuticals Faces Downgrade Following Q2 ResultsAugust 5, 2025 • NewsCompanies mentioned:VRTXVertex Pharmaceuticals shares are trading lower after RBC downgraded its price target to $405 from $430.
